Mutations in KIT, especially inthe juxtamembrane or tyrosine kinase domains, have been detected in a wide variety oftumors including leukemia, gastrointestinal stromal tumors (GISTs), melanomas, and mastcell malignances7, 8, 9, 10. Here, KIT is linked to gastrointestinal stromal tumor.